Skip to main content
SpringerLink
Log in

Onkologische Erkrankungen

  • Chapter
Naturheilverfahren in der Urologie

  • 84 Accesses

Zusammenfassung

Bei onkologischen Erkrankungen der Urogenitalorgane erfolgt die tumorspezifische Behandlung durch Operation, Bestrahlung, Chemotherapie sowie bei einigen Tumoren durch Hormonabsenkung und/oder Immuntherapie.

Im Fachgebiet der Urologie richten sich komplementärmedizinische Maßnahmen mit Ausnahme des Prostatakarzi-noms nicht auf einzelne Tumorentitätfn, sondern gelten generell für den Gesamtkomplex der Urogenitaltumoren (Tabelle 5.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adlercreutz H, Markkanen H, Watanabe S (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209–1210

    Article  PubMed  CAS  Google Scholar 

  • Adlercreutz H, Höckerstedt K, Bannwart C (1977) Effect of dietary components, including lignans and phytoestrogens, an enterohepatic circulation and liver metabolism of estrogens and an sex hormon binding globulin (SHBG).J Steroid Biochem 27:1135–1144

    Article  Google Scholar 

  • Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000) Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels. Cancer Causes Control 11: 847–852

    Article  PubMed  CAS  Google Scholar 

  • Altwein J (1997) Mit Phytoöstrogenen gegen Krebs. DAZ 137:4667–4670

    Google Scholar 

  • Anderson JW, Johnstone BM, Cook-Newel I ME (1995) Metaanalysis of the effects of soy protein intake and serum lipids. N Engl J Med 333:276–282

    Article  PubMed  CAS  Google Scholar 

  • Armanini D, Bonanni G, Palermo M (1999) Reduction of serum testosterone in men by licorice. N Engl J Med 341:1158

    Article  PubMed  CAS  Google Scholar 

  • Aronson WJ, Tymchuk CN, Elashoff RM, McBride WH, McLean C, Wang H, Heber D (1999) Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones. Nutr Cancer 35:130–136

    Article  PubMed  CAS  Google Scholar 

  • Bagnardi V, Blangiardo M, La Vecchia C, Corrao G (2001) A meta-analysis of alcohol drinking and cancer risk. Br J Cancer 85:1700–1705

    Article  PubMed  CAS  Google Scholar 

  • Bairati I, Meyer F, Fradet Y, Moore L (1998) Dietary fat and advanced prostate cancer. J Urol 159:1271–1275

    Article  PubMed  CAS  Google Scholar 

  • Beuth J (2000) Unconventional cancer therapy on trial. Mistletoe preparations: only effective in the test tube? MMW Fortschr Med 142:14

    PubMed  CAS  Google Scholar 

  • Beuth J, Moss RW (2000) Wissenschaftlich begründete komplementäre Therapiemaßnahmen in der Onkologie. Z Onko / J of Oncol 32:2

    Google Scholar 

  • Beuth J, Ko HL, Tunggal L, Gabius HJ, Steuer M, Uhlenbruck G, Pulverer G (1993) Das Lektin in der Mistel in der adjuvanten Therapie beim Mammakarzinom — erste klinische Erfahrungen. Medwelt 44:217–220

    Google Scholar 

  • Blumenfeld AJ, Fleshner N, Casselman B, Trachtenberg J (2000) Nutritional aspects of prostate cancer: a review. Can J Urol 7:927–935

    PubMed  CAS  Google Scholar 

  • Bouffioux Ch, Kurth KH, Bono A, Oosterlinck W, Boeken Kruger C, de Pauw M, Sylvester R, and the members of the European Organization for Research and Treatment of Cancer Genitourinary Group (1995) Intravesical adjuvant chemotherapy for superficial transitional cell bladder carcinoma: Results of 2 European Organization for Research and Treatment of Cancer randomized trials with mitomycin and doxorubicin comparing early versus delayed instillations and short-term versus long-term treatment. J Urol 153:934–941

    Article  PubMed  CAS  Google Scholar 

  • Brosman SA (1982) Experience with bacillus Calmette-Guerin in patients with superficial bladder cancer. Urology 128:27

    CAS  Google Scholar 

  • Clark LC, Dalkin B, Krongrad A et al. (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734

    Article  PubMed  CAS  Google Scholar 

  • Cook NR, Le IM, Manson JE, Buring JE, Hennekens CH (2000) Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians’ Health Study. Cancer Causes Control 11:617–626

    Article  PubMed  CAS  Google Scholar 

  • Corder EH, Guess HA, Hulka BS et al. (1993) Vitamin D and prostate cancer: a predi-agnostic study with stored sera. Cancer Epidemiol Biomarkers Prev 2:467–472

    PubMed  CAS  Google Scholar 

  • De la Taille A (2001) PC SPES in prostatic cancer: critical review of the. Prog Urol 11:428–432

    PubMed  Google Scholar 

  • Dennis LK, Dawson DV (2002) Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 13:72–79

    Article  PubMed  Google Scholar 

  • DiPaola RS, Zhang H, Lambert GH et al. (1998) Clinical and biological activity of an estrogenic herbal combination (PC-SPES) in prostate cancer. N Engl J Med 339: 785–791

    Article  PubMed  CAS  Google Scholar 

  • Fair WR (1999) Back to the future — The role of complementary medicine in urology. J of Urol 162:411–420

    Article  CAS  Google Scholar 

  • Fair WR, Fleshner NE, Heston W (1997) Cancer of the prostate: a nutritional disease? Urology 50:840–848

    Article  PubMed  CAS  Google Scholar 

  • Fawzy Fl, Fawzy N, Hyuns P et al. (1990) Malignant melanoma: effects of an early structured psychiatiric intervention, coping, and affective state an recurrence and survival six years later. Arch Gen Psychiatry 50:681–689

    Article  Google Scholar 

  • Fleischhauer AT, Arab L (2001) Garlic and cancer: A critical review of the epidemiologice. J Nutr 131:1032 S–1040 S

    Google Scholar 

  • Fradet Y, Meyer F, Bairati I, Shadmani R, Moore L (1999) Dietary fat and prostate cancer progression and survival. Eur Urol 35:388–391

    Article  PubMed  CAS  Google Scholar 

  • Freeman VL, Meydani M, Yong S, Pyle J, Wan Y, Arvizu-Durazo R, Liao Y (2000) Prostatic levels of tocopherols, carotenoids, and retinol in relation to plasma levels and self-reported usual dietary intake. Am J Epidemiol 151:109–118

    Article  PubMed  CAS  Google Scholar 

  • Friedenreich CM, Thune I (2001) A review of physical activity and prostate cancer risk. Cancer Causes Control 12:461 – 475

    Article  PubMed  CAS  Google Scholar 

  • Gerdes K (1986) Der Sturz aus der normalen Wirklichkeit und die Suche nach dem Sinn. Ein sozialwissenschaftlicher Beitrag zu Fragen der Krankheitsverarbeitung bei Krebskranken. In: Schmidt W (Hrsg) Jenseits der Nonnalität — Leben mit Krebs. Kaiser, München

    Google Scholar 

  • Giovannucci E (1999) Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologice. J Natl Cancer Inst 91:317–331

    Article  PubMed  CAS  Google Scholar 

  • Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94: 391–398

    Article  PubMed  CAS  Google Scholar 

  • Goebell P, Otto T, Suhr J, Rübben H (2002) Evalutation of unconventional treatment modality with mistle toe lectin to prevent recurrence of superficial bladder cancer. J Urol 168:72–75

    Article  PubMed  Google Scholar 

  • Goepel M, Rübben H (1991) Adjuvant therapy in renal cancer. World J Urol 9:232–236

    Article  Google Scholar 

  • Graham S, Haughey B, Marshall J, Priore R, Byers T, Rzepka T, Mettlin C, Pontes JE (1983) Diet in the epidemiology of carcinoma of the prostate gland. J Natl Cancer Inst 70:687–692

    PubMed  CAS  Google Scholar 

  • Greer S, Moorey S, Watson M (1989) Patients adjustment to cancer: the Mental Adjustment to Cancer (MAC) Scale vs. clinical ratings. J Psychosomat Res 33:373–377

    Article  CAS  Google Scholar 

  • Griffiths K, Khoury S (1994) Primer on molecular control of prostatic growth.Scientific Communications International, Jersey

    Google Scholar 

  • Griffiths K, Denis L, Turkes A, Morton MS (1998) Possible relationship between dietary factors and pathogenesis of prostate cancer. Int J Urol 5:195–213

    Article  PubMed  CAS  Google Scholar 

  • Gross C, Stamey T, Hancock S, Feldman D (1998) Treatment of early recurrent prostate cancer with 1, 25-dihydroxyvitamin D3.J Urol 159:2035–2039

    Article  PubMed  CAS  Google Scholar 

  • Haenszel W, Kurihara M (1968) Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40:43–68

    PubMed  CAS  Google Scholar 

  • Hajto T, Lanzrein C (1986) Natural killer and antibody-dependent cell-mediated cyto-toxity activities and large granular lymphocyte frequencies in viscum album-treated breast cancer patients. Oncology 43:93–97

    Article  PubMed  CAS  Google Scholar 

  • Hajto T, Hostanska K, Gabius HJ (1989) Modulatory potency of the b-galactoside-spe-cific lectin from mistletoe extract (Iscador) on the host defense system in vivo in rabbits and patients. Cancer Res 49:4803–4808

    PubMed  CAS  Google Scholar 

  • Hajto T, Hostanska K, Frei K, Rordorf C, Gabius HJ (1990) Increased secretion of tumor necrosis factor a, interleukin 1, and interleukin 6 by human mononuclear cells exposed to b-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res 50:3322–3326

    PubMed  CAS  Google Scholar 

  • Hajto T, Hostanska K, Fischer J, Lentzen H (1996) Investigations of cellular parameters to establish the response of a biomodulator: galactoside-specific lectin from viscum album plant extract. Phytomedicine 3:129–137

    Article  PubMed  CAS  Google Scholar 

  • Hammar M, Frisk J, Grimas O, Hook, M, Spetz AC, Wyon Y (1999) Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: A pilot study. J Urol 161:853–856

    Article  PubMed  CAS  Google Scholar 

  • Hartman TJ, Albanes D, Pietinen P, Hartman AM, Rautalahti M, Tangrea JA, Taylor PR (1998) The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 7:335–340

    PubMed  CAS  Google Scholar 

  • Hauser SP (1990) Iscador für die Krebsbehandlung: Analyse klinischer Untersuchungsergebnisse. In: Jungi WF, Senn HJ (Hrsg) Krebs und Alternativmedizin II. Springer, Berlin Heidelberg New York Tokyo, S 88–96

    Chapter  Google Scholar 

  • Heinonen OP, Albanes D, Virtamo J (1998) Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440–446

    Article  PubMed  CAS  Google Scholar 

  • Heiny BM (1991) Additive Therapie mit standardisiertem Mistelextrakt produziert die Leukopenie und verbessert die Lebensqualität von Patientinnen mit fortgeschrittenem Mammakarzinom unter palliativer Chemotherapie (VEC-Schema). Krebsmedizin 12

    Google Scholar 

  • Heiny B, Beuth J (1994) Das Lektin der Mistel als Immunmodulator: Effektorwirkung auf b-Endorphin- and Zytokinfreisetzung bei Mammakarzinompatientinnen. Dtsch Z Onkol 26:291–293

    Google Scholar 

  • Heiny BM, Albrecht V, Beuth J (1998) Lebensqualitätsstabilisierung durch Mistellektin-1 normierten Extrakt beim fortgeschrittenen kolorektalen Karzinom. Onkologie 4 [Suppl 1]: 35–39

    Article  Google Scholar 

  • Hsieh T, Chen SS, Wang X, Wu JM (1997) Regulation of androgen receptor (AR) and prostate specific antigen (PSA) expression in the androgen-responsive human prostate LNCaP cells by ethanolic extracts of the Chinese herbal preparation, PC-SPES. Biochem Mol Biol Int 42:535–544

    PubMed  CAS  Google Scholar 

  • Jacobsen BK, Knutsen SF, Fräser GE (1998) Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study. Cancer Causes Control 9:553–557

    Article  PubMed  CAS  Google Scholar 

  • Jain MG, Hislop GT, Howe GR, Ghadirian P (1999) Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr Cancaer 34: 173–184

    Article  CAS  Google Scholar 

  • Kalden M, Wiesenauer M (1994) Immuntherapie. In: Dittmar FW, Loch EG, Wiesenauer M (Hrsg) Naturheilverfahren in der Frauenheilkunde und Geburtshilfe. Hippokrates, Stuttgart, S 287–288

    Google Scholar 

  • Kayser K, Gabius S, Hagemeyer O (1992) Analysis of tumor necrosis factor a-specific, lactose-specific and mistletoe lectin-specific binding sites in human lung carcinomas by labelled ligands. Virchows Archiv A Pathol Anat 421:345–349

    Article  CAS  Google Scholar 

  • Keller J (1954) Urologie. Ein Leitfaden für den Urologen und den urologisch interessierten Praktiker In: Fromme A, Grote LR, Lange F, Naujoks HD (Hrsg) Medizinische Praxis. Steinkopff, Dresden (Sammlung für die medizinische Fortbildung, Bd 37)

    Google Scholar 

  • Kjaer M (1988) Misteltenbehandling of metataserende nyrecancer. En fase II under-sogelse. Ugeskr Laeger 150:1923–1928

    PubMed  CAS  Google Scholar 

  • Klebingat KJ (1998) Unkonventionelle alternative Therapieverfahren in der Palliativen urologischen Onkologie. Urologe B 38:249–251

    Article  Google Scholar 

  • Kleijnen J, Knipschild P (1994) Misteltoe treatment for cancer. Review of controlled trials in humans. Phytomedicine 1:255–260

    Article  PubMed  CAS  Google Scholar 

  • Kraft K (2000) Phytotherapie.Thieme, Stuttgart

    Google Scholar 

  • Krege S, Giani G, Meyer T et al. (1996) A randomized trial of adjuvant therapy in superficial bladder cancer: transurethral resection only versus transurethral resection plus mitomycin C versus transurethral resection plus Bacillus Calmette-Guerin. Urology 156:962

    Article  CAS  Google Scholar 

  • Küchler T, Henne-Bruns D, Rappat S et al. (1999) Impact of psychotherapeutic support an gastrointestinal cancer patients undergoing surgery: survival results of a trial. Hepatogastroenterology 46/25:322–335

    PubMed  Google Scholar 

  • Kucuk O, Sarkar FH, Sakr W et al. (2001) Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev 10:861–868

    PubMed  CAS  Google Scholar 

  • Lamm DL, van der Meijden PM, Morales A et al. (1992) Incidence and treatment of complications of Bacillus Calmette Guerin intravesical therapy in superficial bladder cancer. Urology 147:596

    CAS  Google Scholar 

  • Lamm DL et al.(1994) Megadose vitamins in bladder cancer. A doubble blind clinical trias.J Urol 151:21–26

    CAS  Google Scholar 

  • Leroi R (1975) Klinische Erfahrungen mit dem Mistelpräparat Iscador. In: Wolff O (Hrsg) Die Mistel in der Krebsbehandlung. Klostermann, Frankfurt, S 67–70

    Google Scholar 

  • Madaus G (1938) Lehrbuch der biologischen Heilmittel. Olms, Hildesheim

    Google Scholar 

  • Meyer F, Bairati I, Shadmani R, Fradet Y, Moore L (1999) Dietary fat and prostate cancer survival. Cancer Causes Control 10:245–251

    Article  PubMed  CAS  Google Scholar 

  • Morton MS, Matos-Ferreira A, Abranches-Monteiro L et al. (1997) Measurement and metabolism of isoflavonoids and lignans in the human male. Cancer Lett 114: 145–151

    Article  PubMed  CAS  Google Scholar 

  • Moyad MA, Hathaway S, Ni HS (1999a) Traditional Chinese medicine, acupuncture, and other alternative medicines for prostate cancer: an introduction and the need for more research.. Semin Urol Oncol 17:103–110

    PubMed  CAS  Google Scholar 

  • Moyad MA, Pienta KJ, Montie JE (1999b) Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive disease. Urology 54:319–323

    Article  PubMed  CAS  Google Scholar 

  • Muir CS, Nectoux J, Staszewski J (1991) The epidemiology of prostatic cancer: geographical distribution and timetrends. Acta Oncol 30:133–140

    Article  PubMed  CAS  Google Scholar 

  • Omenn GS, Goodman GE, Thornquist MD et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88:1550–1559

    Article  PubMed  CAS  Google Scholar 

  • Otto T, Lümmen G, Bex A, Suhr J, Raz A, Rübben H (2002) Tumorcell motility/as novel target in cancer. Onkologie 25:172–177

    Article  PubMed  CAS  Google Scholar 

  • Pawinski A, Sylvester R, Kurth KH, Bouffioux C, van der Meijden A, Parmar MKB, Bijnens L for the Members of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on superficial bladder cancer (1996) A combined analysis of European Organization for Research and Treatment of Cancer, and medical research council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. J Urol 156:1934–1941

    Article  PubMed  CAS  Google Scholar 

  • Pfeifer BL, Pirani JF, Hamann SR, Klippel KF (2000) PC-SPES, a dietary supplement for the treatment of hormonerefractory prostate cancer. BJU Int 85:481–485

    Article  PubMed  CAS  Google Scholar 

  • Rafi MM, Rosen RT, Vassil A, Ho CT, Zhang H, Ghai G, Lambert G, DiPaola RS (2000) Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavo-noid. Anticancer Res 20:2653–2658

    PubMed  CAS  Google Scholar 

  • Rafi MM, Vastano BC, Zhu N, Ho CT, Ghai G, Rosen RT, Gallo Ma DiPaola RS (2002) Novel polyphenyl molecule isolated from licirice root (glycrrhia glabra) induces apop-tosis, G2/M cell cycle arrest, and Bcl-2 phosphorylation in tumor cell lines. J Agric Food Chem 50:677–684

    Article  PubMed  CAS  Google Scholar 

  • Roeder G (1978) Mitteilungen aus der Behandlung mit Viscum album. Zur Iscador-Behandlung des Prostatacarzinoms. Verein für Krebsforschung, Ariesheim und Stuttgart, S 13

    Google Scholar 

  • Schmitz-Dräger BJ, Eichholzer M, Beiche B, Ebert T (2001) Nutrition and prostate cancer. Urol Int 67:1–11

    Article  PubMed  Google Scholar 

  • Schröder FH, Kranse R, Dijk MA, Blom JM, Tijburg LM, Weststrate JA, Dagnelie PC (2000) Tertiary prevention of prostatic cancer by dietary intervention: results of a randomized, doubleblind, placebo controlled cross-over study. Eur Urol 37 [Suppl 2]: 24

    Article  Google Scholar 

  • Schwab ED, Normolle D, Pacis RA, Cho SS, Pienta KJ (1998) A high-fat diet does not influence the growth of the Dunning R3327-H transplantable prostate adenocarcinoma. Anticancer Res 18:3603–3607

    PubMed  CAS  Google Scholar 

  • Schwabe U, Paffrath D (2000) Arzneiverordnungsreport 1999. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

  • Severson RK, Nomura AM, Grove JS, Stemmermann GN (1989) A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res 49:1857–1860

    PubMed  CAS  Google Scholar 

  • Sommer F, Peters C, Klotz T, Michna H, Schoenenberger A, Engelmann U (2002) Sport und Bewegung in der Prävention Urologischer Erkrankungen. Urologe B

    Google Scholar 

  • Spiegel D, Bloom JR, Kraemer HC, Gottheil E (1989) Effect of psychosocial treatment an survival of patients with metastatic breast cancer. Lancet 14:888–891

    Article  Google Scholar 

  • Tiwari RK, Geliebter J, Garikapaty VR, Yedavelli SP, Chen S, Mittelman A (1999) Antitumor effects of PC-SPES, an herbal formulation in prostate cancer. Int J Oncol 14: 713–719

    PubMed  CAS  Google Scholar 

  • Van Veldhuizen PJ, Taylor SA, Williamson S, Drees BM (2000) Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol 163:187–190

    Article  PubMed  Google Scholar 

  • Wagner H, Wiesenauer M (1995) Phytotherapie.G.Fischer, Stuttgart

    Google Scholar 

  • Watzl B, Leitzmann C (1999) Bioaktive Substanzen in Lebensmitteln, 2. Aufl. Hippokrates, Stuttgart

    Google Scholar 

  • Wynder EL, Fair WR (1996) Editorial: prostate cancer-nutrition adjunct therapy. J Urol 156:1364

    Article  PubMed  CAS  Google Scholar 

  • Yoshizawa K, Willett WC, Morris SJ, Stampfer MJ, Spiegelman D, Rimm EB, Giovannucci E (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90:1219–1224

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unterer Ahlenbergweg 8, 58313, Herdecke, Deutschland

    Professor Dr. med. Dr. h.c. Jürgen Sökeland (Fachärzte für Urologie) & Professor Dr. med. Dr. h.c. Angelika Sökeland (Fachärzte für Urologie)

Authors
  1. Professor Dr. med. Dr. h.c. Jürgen Sökeland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Professor Dr. med. Dr. h.c. Angelika Sökeland
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Sökeland, J., Sökeland, A. (2003). Onkologische Erkrankungen. In: Naturheilverfahren in der Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08919-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08919-4_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-08920-0

  • Online ISBN: 978-3-662-08919-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation